These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 16473462

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease.
    Winblad B, Grossberg G, Frölich L, Farlow M, Zechner S, Nagel J, Lane R.
    Neurology; 2007 Jul 24; 69(4 Suppl 1):S14-22. PubMed ID: 17646619
    [Abstract] [Full Text] [Related]

  • 3. Acute versus chronic pain treatment in Alzheimer's disease.
    Pickering G, Jourdan D, Dubray C.
    Eur J Pain; 2006 May 24; 10(4):379-84. PubMed ID: 16087372
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. How prior experience shapes placebo analgesia.
    Colloca L, Benedetti F.
    Pain; 2006 Sep 24; 124(1-2):126-33. PubMed ID: 16701952
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H.
    Int J Geriatr Psychiatry; 2007 May 24; 22(5):475-84. PubMed ID: 17471598
    [Abstract] [Full Text] [Related]

  • 11. Relationship between chronic pain and cognition in cognitively intact older persons and in patients with Alzheimer's disease. The need to control for mood.
    Scherder EJ, Eggermont L, Plooij B, Oudshoorn J, Vuijk PJ, Pickering G, Lautenbacher S, Achterberg W, Oosterman J.
    Gerontology; 2008 May 24; 54(1):50-8. PubMed ID: 18185014
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, Sun Y, Perdomo CA, Richardson S.
    Neurology; 2007 Jul 31; 69(5):459-69. PubMed ID: 17664405
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials?
    Cortes F, Portet F, Touchon J, Vellas B.
    J Nutr Health Aging; 2007 Jul 31; 11(4):330-7. PubMed ID: 17653493
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. AMPA potentiator treatment of cognitive deficits in Alzheimer disease.
    Chappell AS, Gonzales C, Williams J, Witte MM, Mohs RC, Sperling R.
    Neurology; 2007 Mar 27; 68(13):1008-12. PubMed ID: 17389305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.